(Q37454779)

20 August 2017

Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study (English)

1 reference

lip and oral cavity carcinoma

20 August 2017

1 reference

1 reference

Takashi Yasuda

1

1 reference

20 August 2017

Hiroshige Chiba

2

1 reference

20 August 2017

Takafumi Satomi

3

1 reference

20 August 2017

Akira Matsuo

4

1 reference

20 August 2017

Tadayoshi Kaneko

5

1 reference

20 August 2017

Daichi Chikazu

6

1 reference

20 August 2017

Hironobu Miyamatsu

7

1 reference

20 August 2017

language of work or name

1 reference

1 January 2012

1 reference

Journal of oral & maxillofacial research

20 August 2017

1 reference

20 August 2017

2

1 reference

20 August 2017

4

1 reference

20 August 2017

e3

1 reference

Pathobiology of oral mucositis: novel insights and opportunities.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Prevention and management of oral mucositis in patients with cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Docetaxel with concurrent radiotherapy in head and neck cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Reporting results of cancer treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Long-Term Surgical Complications in the Oral Cancer Patient: a Comprehensive Review. Part II

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

New strategies for management of oral mucositis in cancer patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

A pilot study of rebamipide-gargle for chemoradiotherapy-induced mucositis in oral cancer patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Prevention by rebamipide of acute reflux esophagitis in rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Development of patient-friendly preparations: preparation of a new allopurinol mouthwash containing polyethylene(oxide) and carrageenan

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886080

A statistical simulation study finds discordance between WHO criteria and RECIST guideline

2 September 2018

1 reference

12 December 2020

Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat

1 reference

12 December 2020

Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil

1 reference

12 December 2020

Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent

1 reference

12 December 2020

Identifiers

DOI

10.5037/JOMR.2011.2403

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24422000

1 reference